Navigation Links
Stem Cell Agency Finally Reveals Institutions Involved in Conflict Problem
Date:12/12/2007

After Public Pressure, Five Research Institutions Are Identified During Grant Award Discussion

LOS ANGELES, Dec. 12 /PRNewswire-USNewswire/ -- The California stem cell agency's decision today to reveal the names of five research institutions whose applications for research grants were rejected because of possible conflict of interest violations was correct, the Foundation for Taxpayer and Consumer Rights (FTCR) said.

But the non-partisan, non-profit organization stressed that the names of the institutions should have been released as soon as the problem came to light.

"Holding back the details simply undermines the public's trust in the stem cell agency," said John M. Simpson, FTCR's Stem Cell Project Director. "I don't understand their propensity for secrecy. It serves neither the board nor the agency nor the public."

The institutions involved are UC San Francisco, UC San Diego, UCLA, University of Southern California and the Burnham Institute for Medical Research. Officials at the institutions who are also members of the stem cell board signed letters supporting applications for research grants.

The 29-member oversight committee met at UCLA today and awarded $54.4 million in grants for young faculty members beginning their research careers. After 10 applications were rejected because of the conflict problem, 48 applications were under consideration. The board approved 22 grants.

It is expected that another call for young faculty grants will be approved at the board's January meeting. The 10 rejected applicants, as well as others, could apply in that round. Before the applications were tossed out, the board expected to authorize $85 million in grants.

"The stem cell agency continues too frequently to operate as if it were a private club or foundation, not the $6 billion state agency it in fact is," said Simpson. "This unwarranted veil of secrecy undermines public trust in the agency and ultimatel
'/>"/>

SOURCE Foundation for Taxpayer and Consumer Rights
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. ImmuneRegen Responds to Defense Threat Reduction Agency Request for Information
2. Pharmion and MethylGene Announce Orphan Drug Designation Granted by the European Medicines Agency (EMEA) for MGCD0103 for the Treatment of Hodgkins Lymphoma
3. International Atomic Energy Agency and National Foundation for Cancer Research Launch Major Initiative to Improve Cancer Prevention and Treatments in Developing Countries
4. Sequella Lead Drug Compound SQ109 Receives Orphan Drug Status From the US FDA and Orphan Medicinal Product Designation From the European Medicines Agency for the Treatment of Tuberculosis
5. New Survey Reveals Many Adults With High Cholesterol Fail to Take Necessary Steps to Improve Their Condition
6. New paper reveals nanoscale details of photolithography process
7. Ohio Academic Institutions Increase Research and Development Investments
8. California Stem Cell Board Member Violates Conflict Rules; Should Resign From Committee, Consumer Group Says
9. A Large-Scale Research Project by a Dutch Consortium Addressing a Global Problem
10. New Licence for Cubicin(R) (daptomycin), the First in a Novel Class of Antibiotic, is Announced Today for the Treatment of Serious Bloodstream and Heart Infections Caused by the Most Problematic UK Organisms, Including MRSA
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2014)... (PRWEB) July 25, 2014 Lawrence Livermore ... to Thomson Reuters list of " The World's Most ... part of the 3,000 researchers who were identified by ... recognize those who published the highest-impact work (2002-2012 and ... papers on combustion modeling . , "This recognition ...
(Date:7/24/2014)... Keryx Biopharmaceuticals, Inc. (Nasdaq:KERX) (the "Company") announced the publication ... 3 study of Zerenex (ferric citrate), the Company,s investigational ... hyperphosphatemia in patients with end-stage renal disease (ESRD) on ... with FErric CiTrate in EsrD) was published online today ... Nephrology ( JASN ). , This ...
(Date:7/24/2014)... , July 24, 2014  ECC West Africa, ... Colorado with University College Hospital (UCH) Ibadan ... development project to finance, design, construct, and operate and ... Nigeria . Under the first of the ... scoping documents and funding applications. UCH Ibadan intends to ...
(Date:7/24/2014)... most natural and synthetic processes prefer to settle ... or energyit is within the realm of non-equilibrium ... constant changes in energy and phases, such as ... conditions allow humans to regulate their body temperature, ... with seismic activity. , But even though ...
Breaking Biology Technology:Scientists Burst onto Influential List for Combustion Research 2Scientists Burst onto Influential List for Combustion Research 3Scientists Burst onto Influential List for Combustion Research 4Zerenex (ferric citrate) long-term Phase 3 study results published in JASN 2Zerenex (ferric citrate) long-term Phase 3 study results published in JASN 3Zerenex (ferric citrate) long-term Phase 3 study results published in JASN 4ECC Signs a Contract for the Finance, Design, and Construction of a Premier Cancer Institute in Ibadan, Nigeria 2New approach to form non-equilibrium structures 2
... LAKE ZURICH, Ill., July 14 Fenwal Inc., a global ... and availability, announced today it has signed a five-year exclusive ... distribute Verax,s unique PanGenera(R) Detection (PGD) technology, a rapid diagnostic ... , , ...
... HORSHOLM, Denmark, July 14 The Board of Directors of,Santaris Pharma has ... - The loss after tax realised in the 2nd quarter of ... DKK (4,0m EUR) in the 2nd, quarter of 2008., ... DKK (23,6m EUR)., - In Q2 ...
... Austria, July 14 Elan Corporation, plc (NYSE: ELN ... week at the Alzheimer Association 2009 International Conference on Alzheimer,s Disease ... growing burden of care and costs associated with Alzheimer,s disease (AD) ... the impact of AD, which, as the population ages, will place ...
Cached Biology Technology:Improving Transfusion Safety: Fenwal, Verax Biomedical Sign Agreement for Rapid, Point-of-Care Bacteria Test 2Improving Transfusion Safety: Fenwal, Verax Biomedical Sign Agreement for Rapid, Point-of-Care Bacteria Test 3Santaris Pharma - Interim Report for the Period 1 January to 30 June 2009 2Santaris Pharma - Interim Report for the Period 1 January to 30 June 2009 3Santaris Pharma - Interim Report for the Period 1 January to 30 June 2009 4Santaris Pharma - Interim Report for the Period 1 January to 30 June 2009 5Santaris Pharma - Interim Report for the Period 1 January to 30 June 2009 6Santaris Pharma - Interim Report for the Period 1 January to 30 June 2009 7Santaris Pharma - Interim Report for the Period 1 January to 30 June 2009 8Santaris Pharma - Interim Report for the Period 1 January to 30 June 2009 9Studies Presented at International Conference on Alzheimer's Disease Reveal Substantial Economic Costs and Caregiver Burden Associated with Alzheimer's Disease 2Studies Presented at International Conference on Alzheimer's Disease Reveal Substantial Economic Costs and Caregiver Burden Associated with Alzheimer's Disease 3Studies Presented at International Conference on Alzheimer's Disease Reveal Substantial Economic Costs and Caregiver Burden Associated with Alzheimer's Disease 4Studies Presented at International Conference on Alzheimer's Disease Reveal Substantial Economic Costs and Caregiver Burden Associated with Alzheimer's Disease 5Studies Presented at International Conference on Alzheimer's Disease Reveal Substantial Economic Costs and Caregiver Burden Associated with Alzheimer's Disease 6Studies Presented at International Conference on Alzheimer's Disease Reveal Substantial Economic Costs and Caregiver Burden Associated with Alzheimer's Disease 7
(Date:7/24/2014)... MADISON A multi-institutional team of researchers has developed ... tract. This safe, noninvasive method for assessing the function ... could lead to better diagnosis and treatment of gut ... bacterial overgrowth, irritable bowel syndrome and inflammatory bowel disease ... serious side effects in patients with diseases such as ...
(Date:7/24/2014)... similar counterparts in humans, affect the connections between nerve ... the hippocampus, an area of the brain that plays ... of memories. The results of the study have been ... function depends on the active communication between nerve cells, ... together into a dense network where they constantly relay ...
(Date:7/24/2014)... in the United States, wildland managers often utilize the ... trees (ladder fuels). These cuttings and other post-logging ... danger in order to dispose of the material. To ... often cover all or part of the debris pile ... plastic, in order to keep water out. A recent ...
Breaking Biology News(10 mins):New imaging agent provides better picture of the gut 2A protein couple controls flow of information into the brain's memory center 2A protein couple controls flow of information into the brain's memory center 3A protein couple controls flow of information into the brain's memory center 4Study gives new perspective on agricultural plastic, debris burning, and air quality 2
... The deposition of amyloid beta in the brain of ... into both its cause and treatment. While there ... contributes to the disease or is a consequence of the ... meaning that something else is promoting the process. Other ...
... Have you ever been disappointed by a cantaloupe from the ... researchers from the University of California, Davis might have found ... the past. The method will be published on March 30 ... ). "We are involved in a project geared towards ...
... if there is a link between living near nuclear power ... of cancer, but challenges and limitations exist, says a new ... the National Academy of Sciences and National Academy of Engineering. ... first to evaluate the feasibility of a full-scale study, although ...
Cached Biology News:The electronic nose knows when your cantaloupe is ripe 2Report presents designs for study of cancer risks near US nuclear facilities 2Report presents designs for study of cancer risks near US nuclear facilities 3
...
...
... White solid. PROTECT FROM LIGHT. ... sulfanamido-benzbromarone compound that acts as a ... of PTP1B (IC 50 = ... PTP1B 403 and PTP1B 298 ...
...
Biology Products: